









Markets
/
Stocks
/
nasdaq-gdtc
/

CytoMed Therapeutics Ltd

GDTC

1.405USD

-0.155-9.94%

Close 12/19, 16:00（ET）Quotes delayed by 15 min

16.20MMarket Cap

LossP/E TTM



CytoMed Therapeutics Ltd

1.405

-0.155-9.94%

Overview Company Financials Analysis

Overview

Company

Financials

Analysis

You can check out the annual or quarterly balance sheets of CytoMed Therapeutics Ltd here to evaluate the financial health, analyze fundamentals, and calculate key ratios for liquidity, leverage, and return on equity.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2024H2

FY2024H1

FY2023H2

FY2023H1

FY2022H2

FY2022H1

FY2021H2

FY2021H1

Total equity

Cash, cash equivalents and short-term investments

-42.48%3.80M

-35.20%5.04M

458.66%6.60M

600.61%7.77M

-36.94%1.18M

-61.08%1.11M

--1.87M

--2.85M

- Cash and cash equivalents

-42.48%3.80M

-35.20%5.04M

458.66%6.60M

600.61%7.77M

-36.94%1.18M

-61.08%1.11M

--1.87M

--2.85M

Receivables

-38.38%92.64K

-55.59%38.01K

248.87%150.34K

765.00%85.60K

991.85%43.09K

1868.45%9.90K

--3.95K

--502.74

-Accounts and notes receivable

--14.35K

----

-Loans receivable

----

--0.00

----

-Other receivables

-49.40%76.07K

-55.59%38.01K

248.87%150.34K

1141.71%85.60K

991.85%43.09K

1271.27%6.89K

--3.95K

--502.74

Inventory

----

--234.80K

Prepaid expenses

9.18%671.56K

-2.25%650.60K

-2.27%615.12K

30.51%665.61K

12.71%629.40K

15.02%510.00K

--558.42K

--443.41K

Other current assets

-46.34%23.28K

1538.17%273.37K

272.49%43.38K

45.68%16.69K

2.48%11.65K

51.02%11.45K

--11.36K

--7.59K

Total current assets

-38.14%4.59M

-29.77%6.00M

297.22%7.41M

420.54%8.54M

-23.77%1.87M

-53.61%1.64M

--2.45M

--3.54M

Non-current assets

Net Fixed Assets

63.99%2.49M

17.15%1.93M

-18.15%1.52M

-17.72%1.65M

-0.53%1.85M

29.08%2.00M

--1.86M

--1.55M

-Fixed Assets

52.36%3.84M

----

-4.62%2.52M

----

9.43%2.64M

35.50%2.67M

--2.41M

--1.97M

-Accumulated depreciation

34.76%1.35M

----

27.19%1.00M

----

43.15%787.85K

59.16%670.01K

--550.38K

--420.96K

Goodwill and other intangible assets

680.27%71.12K

-16.70%8.57K

-35.25%9.11K

-45.73%10.29K

-41.08%14.08K

-32.93%18.96K

--23.89K

--28.27K

Total non-current assets

86.31%3.11M

36.81%2.49M

-18.43%1.67M

-17.34%1.82M

-2.11%2.05M

39.51%2.20M

--2.09M

--1.58M

Total assets

-15.28%7.69M

-18.06%8.49M

132.17%9.08M

169.53%10.36M

-13.80%3.91M

-24.86%3.84M

--4.54M

--5.12M

Liabilities

Current liabilities

-Other payables

-24.53%29.58K

66.23%23.20K

-68.19%39.19K

-67.58%13.96K

522.60%123.18K

124.47%43.05K

--19.79K

--19.18K

Accrued expenses

-15.24%277.97K

35.22%188.02K

84.76%327.95K

103.33%139.05K

62.99%177.50K

-25.43%68.38K

--108.91K

--91.71K

Short-term debt and lease liabilities

18.73%35.09K

-4.61%29.10K

-98.95%29.55K

-98.56%30.51K

38.86%2.80M

13.03%2.12M

--2.02M

--1.88M

-Short-term debt

--0.00

----

-100.00%0.00

39.53%2.77M

13.34%2.09M

--1.99M

--1.84M

-Short-term lease liabilities

35.99%6.31K

----

-19.52%4.64K

-4.03%5.59K

-1.02%5.77K

4.35%5.82K

--5.83K

--5.58K

Deferred liabilities

1955.49%82.35K

-18.03%3.36K

52.77%4.01K

-58.09%4.10K

-73.95%2.62K

-0.90%9.78K

--10.07K

--9.87K

Other current liabilities

159.11%111.92K

38.43%26.56K

-65.99%43.20K

-63.68%19.19K

325.43%127.00K

81.87%52.83K

--29.85K

--29.05K

Total current liabilities

-11.93%463.64K

18.79%278.58K

-83.11%526.43K

-89.78%234.51K

42.28%3.12M

12.02%2.29M

--2.19M

--2.05M

Non-current liabilities

Long-term debt and lease liabilities

0.65%301.37K

-4.69%304.25K

-14.66%299.41K

-15.87%319.22K

-12.77%350.87K

-7.36%379.45K

--402.24K

--409.60K

-Long-term debt

0.65%301.37K

-4.69%304.25K

-14.66%299.41K

-15.87%319.22K

-12.77%350.87K

-7.36%379.45K

--402.24K

--409.60K

Total non-current liabilities

6.53%318.97K

-5.26%304.25K

-15.87%299.41K

-17.16%321.14K

-13.97%355.89K

-8.50%387.66K

--413.67K

--423.69K

Total liabilities

-5.24%782.60K

4.89%582.83K

-76.22%825.84K

-79.28%555.65K

33.35%3.47M

8.50%2.68M

--2.60M

--2.47M

Shareholders' equity

Common equity

4.09%18.19M

4.83%18.52M

161.92%17.47M

207.89%17.67M

16.25%6.67M

1.95%5.74M

--5.74M

--5.63M

Retained earnings

-24.71%-11.29M

-35.42%-10.45M

-47.57%-9.05M

-70.52%-7.71M

-62.29%-6.14M

-52.96%-4.52M

---3.78M

---2.96M

Capital reserves

----

--0.00

--54.28K

----

-100.00%0.00

--851.60K

--1.46M

Gains losses not affecting retained earnings

74.26%-41.09K

-14.39%-165.01K

-67.31%-159.63K

-183.56%-144.26K

-312.77%-95.41K

-104.35%-50.88K

---23.11K

---24.90K

Non-controlling interests

8565.29%59.42K

-39.98%-856.94

-37.53%-701.96

-51.11%-612.20

-55.83%-510.40

-76.31%-405.13

---327.54

---229.78

Total equity

-16.28%6.91M

-19.36%7.91M

1781.63%8.26M

743.19%9.81M

-77.31%438.78K

-56.03%1.16M

--1.93M

--2.65M

Currency unit

USD

Audit opinions

FAQs

What is the balance sheet?



It is a financial report that summarises the assets, liabilities, and shareholders’ equity of a company at a specific point in time.

KeyAI

